Hrt Financial LP Alterity Therapeutics LTD Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$0.01 - $0.02 $113 - $227
11,384 New
11,384 $6,000
Q4 2021

Feb 14, 2022
SELL
$0.01 - $0.02 $106 - $212
-10,610 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$0.02 - $0.03 $347 - $521
-17,382 Reduced 62.1%
10,610 $13,000
Q2 2021

Aug 16, 2021
BUY
$0.02 - $0.03 $559 - $839
27,992 New
27,992 $36,000

Others Institutions Holding ATHE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ALTERITY THERAPEUTICS LTD

ATHE Quotes by TradingView
  • Ticker ATHE
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,114,600
  • Market Cap $149M
  • Description
  • Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also...
More about ATHE
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email